Rhythm Pharmaceuticals
RYTM
RYTM
119 hedge funds and large institutions have $1.19B invested in Rhythm Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 40
43% less call options, than puts
Call options by funds: $3.31M | Put options by funds: $5.81M
Holders
119
Holding in Top 10
2
Calls
$3.31M
Puts
$5.81M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$22.8M | |
| 3 | +$11.7M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$11.5M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$10.4M |
Top Sellers
| 1 | -$28.6M | |
| 2 | -$8.12M | |
| 3 | -$5.59M | |
| 4 |
Renaissance Technologies
New York
|
-$5.55M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$4.65M |